
Hagop Kantarjian/mdanderson.org
Feb 26, 2025, 16:33
Hagop Kantarjian: Treatment-free remission in non-transplanted Ph+ ALL patients
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, posted on X about recent paper by Eitan Kugler et al., titled “Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemia” published on ACS Journals.
Authors: Eitan Kugler, Hagop Kantarjian, Elias Jabbour, Niranjan Khaire, Nicholas J. Short, Tapan M. Kadia, Fadi G. Haddad, Koji Sasaki, Rashmi Kanagal Shamanna, Rebecca Garris, Farhad Ravandi, Nitin Jain
“Treatment-free remission in non-transplanted Ph+ ALL patients is feasible in carefully selected pts. Those in CR1 (n=6) who maintained CMR for >48 mos did not relapse following TKI discontinuation.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 26, 2025, 16:32
Feb 26, 2025, 16:31
Feb 26, 2025, 15:47
Feb 26, 2025, 15:38
Feb 26, 2025, 15:34
Feb 26, 2025, 15:33
Feb 26, 2025, 15:22